Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health Service

Background. There is a paucity of research in Australia on the characteristics of women in treatment for illicit substance use in pregnancy and the health outcomes of their neonates. Aims. To determine the clinical features and outcomes of high-risk, marginalized women seeking treatment for illicit...

Full description

Saved in:
Bibliographic Details
Main Authors: Lee Taylor, Delyse Hutchinson, Ron Rapee, Lucy Burns, Christine Stephens, Paul S. Haber
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Obstetrics and Gynecology International
Online Access:http://dx.doi.org/10.1155/2012/867265
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547565952827392
author Lee Taylor
Delyse Hutchinson
Ron Rapee
Lucy Burns
Christine Stephens
Paul S. Haber
author_facet Lee Taylor
Delyse Hutchinson
Ron Rapee
Lucy Burns
Christine Stephens
Paul S. Haber
author_sort Lee Taylor
collection DOAJ
description Background. There is a paucity of research in Australia on the characteristics of women in treatment for illicit substance use in pregnancy and the health outcomes of their neonates. Aims. To determine the clinical features and outcomes of high-risk, marginalized women seeking treatment for illicit substance use in pregnancy and their neonates. Methods. 139 women with a history of substance abuse/dependence engaged with a perinatal drug health service in Sydney, Australia. Maternal (demographic, drug use, psychological, physical, obstetric, and antenatal care) and neonatal characteristics (delivery, early health outcomes) were examined. Results. Compared to national figures, pregnant women attending a specialist perinatal and family drug health service were more likely to report being Australian born, Aboriginal or Torres Strait Islander, younger, unemployed, and multiparous. Opiates were the primary drug of concern (81.3%). Pregnancy complications were common (61.9%). Neonates were more likely to be preterm, have low birth weight, and be admitted to special care nursery. NAS was the most prevalent birth complication (69.8%) and almost half required pharmacotherapy. Conclusion. Mother-infant dyads affected by substance use in pregnancy are at significant risk. There is a need to review clinical models of care and examine the longer-term impacts on infant development.
format Article
id doaj-art-411e45f84eb04c7f80d6cf76cd7eac64
institution Kabale University
issn 1687-9589
1687-9597
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Obstetrics and Gynecology International
spelling doaj-art-411e45f84eb04c7f80d6cf76cd7eac642025-02-03T06:44:21ZengWileyObstetrics and Gynecology International1687-95891687-95972012-01-01201210.1155/2012/867265867265Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health ServiceLee Taylor0Delyse Hutchinson1Ron Rapee2Lucy Burns3Christine Stephens4Paul S. Haber5School of Psychology, Macquarie University, Sydney, NSW 2113, AustraliaNational Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, AustraliaSchool of Psychology, Macquarie University, Sydney, NSW 2113, AustraliaNational Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, AustraliaDrug Health Services, Royal Prince Alfred Hospital, Camperdown, NSW 2050, AustraliaNational Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, AustraliaBackground. There is a paucity of research in Australia on the characteristics of women in treatment for illicit substance use in pregnancy and the health outcomes of their neonates. Aims. To determine the clinical features and outcomes of high-risk, marginalized women seeking treatment for illicit substance use in pregnancy and their neonates. Methods. 139 women with a history of substance abuse/dependence engaged with a perinatal drug health service in Sydney, Australia. Maternal (demographic, drug use, psychological, physical, obstetric, and antenatal care) and neonatal characteristics (delivery, early health outcomes) were examined. Results. Compared to national figures, pregnant women attending a specialist perinatal and family drug health service were more likely to report being Australian born, Aboriginal or Torres Strait Islander, younger, unemployed, and multiparous. Opiates were the primary drug of concern (81.3%). Pregnancy complications were common (61.9%). Neonates were more likely to be preterm, have low birth weight, and be admitted to special care nursery. NAS was the most prevalent birth complication (69.8%) and almost half required pharmacotherapy. Conclusion. Mother-infant dyads affected by substance use in pregnancy are at significant risk. There is a need to review clinical models of care and examine the longer-term impacts on infant development.http://dx.doi.org/10.1155/2012/867265
spellingShingle Lee Taylor
Delyse Hutchinson
Ron Rapee
Lucy Burns
Christine Stephens
Paul S. Haber
Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health Service
Obstetrics and Gynecology International
title Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health Service
title_full Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health Service
title_fullStr Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health Service
title_full_unstemmed Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health Service
title_short Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health Service
title_sort clinical features and correlates of outcomes for high risk marginalized mothers and newborn infants engaged with a specialist perinatal and family drug health service
url http://dx.doi.org/10.1155/2012/867265
work_keys_str_mv AT leetaylor clinicalfeaturesandcorrelatesofoutcomesforhighriskmarginalizedmothersandnewborninfantsengagedwithaspecialistperinatalandfamilydrughealthservice
AT delysehutchinson clinicalfeaturesandcorrelatesofoutcomesforhighriskmarginalizedmothersandnewborninfantsengagedwithaspecialistperinatalandfamilydrughealthservice
AT ronrapee clinicalfeaturesandcorrelatesofoutcomesforhighriskmarginalizedmothersandnewborninfantsengagedwithaspecialistperinatalandfamilydrughealthservice
AT lucyburns clinicalfeaturesandcorrelatesofoutcomesforhighriskmarginalizedmothersandnewborninfantsengagedwithaspecialistperinatalandfamilydrughealthservice
AT christinestephens clinicalfeaturesandcorrelatesofoutcomesforhighriskmarginalizedmothersandnewborninfantsengagedwithaspecialistperinatalandfamilydrughealthservice
AT paulshaber clinicalfeaturesandcorrelatesofoutcomesforhighriskmarginalizedmothersandnewborninfantsengagedwithaspecialistperinatalandfamilydrughealthservice